Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection.
about
Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effectsEffect of chronic fluoxetine treatment on male and female rat erythrocyte and prefrontal cortex fatty acid composition.Liquid chromatographic enantioseparation of (RS)-mexiletine and (RS)-fluoxetine using chiral derivatizing reagents synthesized with (S)-naproxen moiety.Stereo-specific LC and LC-MS bioassays of antidepressants and psychotics.Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Omega-3 fatty acid deficiency does not alter the effects of chronic fluoxetine treatment on central serotonin turnover or behavior in the forced swim test in female rats.Chiral determination of antidepressant drugs and their metabolites in biological samples.Quantitative analysis of drugs in biological matrices by HPLC hyphenated to fluorescence detection.Analytical methodologies for the stereoselective determination of fluoxetine: An overview.A novel chiral GC/MS method for the analysis of fluoxetine and norfluoxetine enantiomers in biological fluids.Fluoxetine treatment is effective in a rat model of childhood-induced post-traumatic stress disorder.Influence of gasoline inhalation on the enantioselective pharmacokinetics of fluoxetine in rats.Determination of Fluoxetine in Human Plasma by Liquid Chromatography–Mass Spectrometry and Its Application
P2860
Q28578394-CD69A729-631D-429F-B9DE-996D8AD4CE2CQ34126331-67843051-850E-421B-ABBE-F966778839A5Q35174131-B871F1FB-2B3D-424F-890B-766732435E25Q35376254-0579AF85-9EAA-470E-872C-DEB04BCC74D2Q36502629-37C5E8AD-721A-48B5-9A70-82DA20560EBFQ37353739-FB3C6DA3-E29D-4BB6-BAF9-704122152EA5Q37810213-046B2320-DFFA-4C2C-9A31-05FBDE512C49Q38420117-24FF51FC-AB2A-4F67-A15C-FE7959D843BEQ39410693-68509AD8-4F8A-4B8A-975F-A331FDA85FB2Q41821006-C20D03C0-0994-4A68-BE20-96F8D84AD973Q47943877-99D1B69A-4647-46E1-B089-EC8D4C017AA3Q48528627-118BE0AD-6E90-4862-996A-5613CD1A8DFAQ58135788-90B80AD2-0C4D-4A4C-9B5E-53BC15611939
P2860
Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Determination of fluoxetine, n ...... y with fluorescence detection.
@en
Determination of fluoxetine, n ...... y with fluorescence detection.
@nl
type
label
Determination of fluoxetine, n ...... y with fluorescence detection.
@en
Determination of fluoxetine, n ...... y with fluorescence detection.
@nl
prefLabel
Determination of fluoxetine, n ...... y with fluorescence detection.
@en
Determination of fluoxetine, n ...... y with fluorescence detection.
@nl
P50
P1476
Determination of fluoxetine, n ...... hy with fluorescence detection
@en
P2093
Iñigo Ruiz de Azúa
Nora Unceta
P304
P356
10.1016/J.JCHROMB.2007.02.008
P577
2007-02-15T00:00:00Z